VistaGen Therapeutics
Price & Volume
Stats
See more52W Range | $1.90-$3.79 |
Market Cap | $88.6M |
Shares Short | 502,316 |
Financials
See moreRevenue (12 Mos) | $486,000 |
Revenue Growth (YoY) | -43.1% |
Gross Profit (12 Mos) | $486,000 |
Diluted EPS | -$1.67 |
News
See moreYahoo Finance • 5 days ago
VistaGen Therapeutics Inc Q1 Sales Increase
Yahoo Finance • 2 months ago
Vistagen appoints Elissa Cote as Chief Corporate Development Officer
Yahoo Finance • 2 months ago
Stifel reiterates buy rating on VistaGen stock amid clinical progress
Yahoo Finance • 2 months ago
Earnings call transcript: Vistagen's focus on innovation amid rising expenses Q1 2025
About
CEO | Mr. Shawn K. Singh J.D. |
Address | 343 Allerton Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 56 |
